| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 13 | |
| #2 | Canada | 3 | |
| #3 | Australia | 2 | |
| #4 | Mexico | 2 | |
| #5 | WIPO (World Intellectual Property Organization) | 2 | |
| #6 | Brazil | 1 | |
| #7 | EPO (European Patent Office) | 1 | |
| #8 | Republic of Korea | 1 | |
| #9 | New Zealand | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Heterocyclic compounds | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Cole Bridget M | 23 |
| #2 | Nugent Richard A | 17 |
| #3 | Kolodziej Andrew | 11 |
| #4 | Barsukov Yevgen | 11 |
| #5 | Handley Karen | 9 |
| #6 | Zawistoski Michael P | 5 |
| #7 | Smith Paul T | 4 |
| #8 | Richard A Nugent | 2 |
| #9 | Paul T Smith | 2 |
| #10 | Smith Jr Paul T | 2 |
| Publication | Filing date | Title |
|---|---|---|
| WO2020160010A1 | Compounds and methods for the treatment of cystic fibrosis | |
| WO2017117239A1 | Compounds and methods for the treatment of cystic fibrosis | |
| AU2015328307A1 | Triazolopyridine compounds and methods for the treatment of cystic fibrosis | |
| US2014371263A1 | Compounds and methods for the treatment of cystic fibrosis |